The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.

The stock, which is down more than 61% in 2025, sold off after reporting a Q3 EPS beat missing on revenue expectations.

Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. Learn more about VERX stock here.

One key figure, however, indicates otherwise as sales for Journavx were at $20 million for the period, coming up $3 million ...

The potential approval of Vertex’s IgAN therapy povetacicept in 2026 comes amid launch headwinds for the company’s non-opioid ...

Vertex stock dipped late Monday despite better-than-expected third-quarter metrics and a slight sales guidance boost.

BMO Capital analyst Daniel Jester lowered the firm’s price target on Vertex (VERX) to $24 from $30 and keeps a Market Perform rating on the ...

For 150 years, Broca's area has defined speech production. Now scientists have discovered a second parallel system that ...

Return on Assets (ROA): Vertex's financial strength is reflected in its exceptional ROA, which exceeds industry averages.

Something deadly might be wafting through the clouds shrouding Venus—a smelly, flammable gas called phosphine that annihilates life-forms reliant on oxygen for survival. Ironically, though, the ...